Evidence map›Paper›PMID 39735502›Full record

ArticleNetwork neuroscience (Cambridge, Mass.)2024

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease.

Jiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, Andrew Eck, Babatunde Adeyemo, Abraham Z Snyder, Alisha Daniels, Celeste Karch, Edward D Huey, Eric McDade and 17 more

Erratum issuedAbstract read
In one paragraph

Article in Network neuroscience (Cambridge, Mass.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Jiaxin Cindy TuDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.ORCID https://orcid.org/0000-0003-1982-9890
Peter R MillarDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Jeremy F StrainDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Andrew EckDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Babatunde AdeyemoDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Abraham Z SnyderDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Alisha DanielsDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Celeste KarchDepartment of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA.
Edward D HueyDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Eric McDadeDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Gregory S DayDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Igor YakushevDepartment of Nuclear Medicine, Technical University of Munich, Munich, Germany.
Jason HassenstabDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
John MorrisDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Jorge J Llibre-GuerraDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Laura IbanezDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Mathias JuckerDepartment of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Patricio Chrem MendezMemory Center, Fleni, Argentina.
Richard J PerrinDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Tammie L S BenzingerDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Richard BetzelDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.
Beau M AncesDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Adam T EggebrechtDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Brian A GordonDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Muriah D WheelockDepartment of Radiology, Washington University in St. Louis, St. Louis, MO, USA.ORCID https://orcid.org/0000-0002-3409-8777
Dominantly Inherited Alzheimer Network

Funding

Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI Carlos Cruchaga · 2020 to 2026
$28.7M
Genetic basis of neuropsychiatric symptoms in Alzheimer's diseaseU01AG079850 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gary Wayne Beecham, Edward D Huey · 2023 to 2026
$3.0M
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's diseaseR01AG062268 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HUEY, EDWARD D · 2018 to 2022
$2.5M
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related DementiasR01MH120794 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HUEY, EDWARD D · 2019 to 2023
$2.1M
Innovative biostatistical approaches to network level analyses of connectome-behavior relationshipsR00EB029343 · NIBIB · WASHINGTON UNIVERSITY · PI WHEELOCK, MURIAH D · 2022 to 2024
$955k
Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer DiseaseK01AG053474 · NIA · WASHINGTON UNIVERSITY · PI GORDON, BRIAN ANDREW · 2017 to 2021
$623k
Network level analysis of progressive brain degeneration in autosomal dominant Alzheimer diseaseK99EB029343 · NIBIB · WASHINGTON UNIVERSITY · PI WHEELOCK, MURIAH D · 2020 to 2021
$484k
NIA NIH HHS K01 AG053474NIA NIH HHS P30 AG066444NIA NIH HHS R01 AG062268NIA NIH HHS U01 AG079850NIBIB NIH HHS K99 EB029343NIBIB NIH HHS R00 EB029343NIMH NIH HHS R01 MH120794
6 · The paper itself

Abstract

Hub regions in the brain, recognized for their roles in ensuring efficient information transfer, are vulnerable to pathological alterations in neurodegenerative conditions, including Alzheimer's disease (AD). Computational simulations and animal experiments have hinted at the theory of activity-dependent degeneration as the cause of this hub vulnerability. However, two critical issues remain unresolved. First, past research has not clearly distinguished between two scenarios: hub regions facing a higher risk of connectivity disruption (targeted attack) and all regions having an equal risk (random attack). Second, human studies offering support for activity-dependent explanations remain scarce. We refined the hub disruption index to demonstrate a hub disruption pattern in functional connectivity in autosomal dominant AD that aligned with targeted attacks. This hub disruption is detectable even in preclinical stages, 12 years before the expected symptom onset and is amplified alongside symptomatic progression. Moreover, hub disruption was primarily tied to regional differences in global connectivity and sequentially followed changes observed in amyloid-beta positron emission tomography cortical markers, consistent with the activity-dependent degeneration explanation. Taken together, our findings deepen the understanding of brain network organization in neurodegenerative diseases and could be instrumental in refining diagnostic and targeted therapeutic strategies for AD in the future.

Indexed as

Alzheimer’s diseaseBiomarkerFunctional connectivityHubsNeurodegeneration

Identifiers

PMID39735502
PMCPMC11674321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.